CNN Just Ran One of the Worst AI Puff Pieces We’ve Ever Seen in Our Lives About That “AI Actor” Tilly Northwood15m ago How Credit Genie keeps codebase docs fresh with OpenWiki18m ago Closing The Gap Between AI Ambition And Data Reality18m ago ElevenLabs signs its first major-label deal, licensing Universal music for a fan remix platform24m ago Top Pentagon official dismisses viral AI warning from an Anthropic researcher25m ago Arlequin AI raises €28M to build novel AI models that learn complex relationships at scale28m ago SpaceX sues to block release of tax-break records for its Texas Terafab project28m ago Salesforce closes Fin and eyes $2bn Listen Labs, Business Insider reports29m ago Google brings Gemini for desktop app to Windows30m ago AI’s Hidden Apprenticeship Tax (And How Firms Can Avoid It)33m ago Abacus.AI Releases Three Open-Weight Smaug Models for Agentic Workloads38m ago Clay raises $115m at a $7.1bn valuation, more than double its 2025 price40m ago Before AI Agents Take Action, Enterprises Need A New Data Rule Book48m ago Feature Engineering in Scikit-Learn: A KDnuggets Cheat Sheet49m ago

CNN Just Ran One of the Worst AI Puff Pieces We’ve Ever Seen in Our Lives About That “AI Actor” Tilly Northwood15m ago How Credit Genie keeps codebase docs fresh with OpenWiki18m ago Closing The Gap Between AI Ambition And Data Reality18m ago ElevenLabs signs its first major-label deal, licensing Universal music for a fan remix platform24m ago Top Pentagon official dismisses viral AI warning from an Anthropic researcher25m ago Arlequin AI raises €28M to build novel AI models that learn complex relationships at scale28m ago SpaceX sues to block release of tax-break records for its Texas Terafab project28m ago Salesforce closes Fin and eyes $2bn Listen Labs, Business Insider reports29m ago Google brings Gemini for desktop app to Windows30m ago AI’s Hidden Apprenticeship Tax (And How Firms Can Avoid It)33m ago Abacus.AI Releases Three Open-Weight Smaug Models for Agentic Workloads38m ago Clay raises $115m at a $7.1bn valuation, more than double its 2025 price40m ago Before AI Agents Take Action, Enterprises Need A New Data Rule Book48m ago Feature Engineering in Scikit-Learn: A KDnuggets Cheat Sheet49m ago

Healthcare AI Research10 min reading time

Thomas Clozel, M.D., Co-Founder and CEO of Owkin – Interview Series

Unite.AIPublished 50 minutes ago

Thomas Clozel, co-founder and CEO of Owkin, leads the AI biotech company in developing autonomous AI systems to accelerate drug discovery by integrating diverse biomedical data. Founded in 2016, Owkin partners with major pharma firms and aims to create Biological Artificial SuperIntelligence to autonomously conduct drug research.

#biomedical-research #bristol-myers-squibb #msd #owkin #sanofi #thomas-clozel

More in Healthcare

UK Is Urged to Overhaul Regulation of AI-Medical Devices

Covered by 2 sources18h ago

How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules

Open AI News1h ago

Healthcare6 min read

NYU-DRP AI Model Predicts Five-Year Breast Cancer Risk From 3D Mammograms

Unite.AI6h ago